Skip to main content

Table 3 MICs (μg/ml) of quinolones for different colonies of E coli KZM120 containing each of the plasmids pBS3.8, pBS3.25 and pBS3.13

From: Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants

Plasmids Antibiotics
  NAL NOR SPA CIP ENX LEV GAR GRP TRV MOX
pGEM-T 1 0.016 0.032 0.002 0.032 0.004 0.002 0.001 0.004 0.004
pBS3.8 1 1 0.032 0.032 0.008 0.064 0.016 0.032 0.008 0.032 0.016
pBS3.8 2 1 0.016 0.032 0.004 0.064 0.008 0.016 0.008 0.032 0.016
pBS3.8 3 1 0.016 0.032 0.004 0.064 0.008 0.016 0.008 0.032 0.016
pBS3.13 1 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.016
pBS3.13 2 1 0.016 0.032 0.004 0.064 0.008 0.002 0.002 0.008 0.008
pBS3.13 3 1 0.016 0.032 0.004 0.064 0.008 0.002 0.002 0.008 0.008
pBS3.25 1 1 0.016 0.032 0.004 0.064 0.008 0.064 0.016 0.032 0.032
pBS3.25 2 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.008
pBS3.25 3 1 0.016 0.032 0.004 0.064 0.008 0.008 0.004 0.016 0.008
  1. Three colonies were tested for each plasmid.
  2. NAL; nalidixic acid, NOR; norfloxacin, SPA; sparfloxacin, CIP; ciprofloxacin, ENX; enoxacin, LEV; levofloxacin, GAR; garenoxacin, GRP; grepafloxacin, TRV; trovafloxacin, MOX; moxifloxacin.
\